Inhibitors | Comment | Organism | Structure |
---|---|---|---|
oleoyl ethylamide | FAAH inhibitor | Homo sapiens | |
oleoyl ethylamide | FAAH inhibitor | Mus musculus | |
oleoyl ethylamide | FAAH inhibitor | Rattus norvegicus | |
palmitoyl ethanolamide | a non-CB1 non-CB2 cannabinoid-like compound | Homo sapiens | |
palmitoyl ethanolamide | a non-CB1 non-CB2 cannabinoid-like compound | Mus musculus | |
palmitoyl ethanolamide | a non-CB1 non-CB2 cannabinoid-like compound | Rattus norvegicus | |
URB597 | FAAH inhibitor | Homo sapiens | |
URB597 | FAAH inhibitor | Mus musculus | |
URB597 | FAAH inhibitor | Rattus norvegicus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
63000 | - |
x * 63000, about, SDS-PAGE | Mus musculus |
63000 | - |
x * 63000, about, SDS-PAGE | Homo sapiens |
63000 | - |
x * 63000, about, SDS-PAGE | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
anandamide + H2O | Mus musculus | i.e. arachidonoyl ethanolamide | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | Homo sapiens | i.e. arachidonoyl ethanolamide | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | Rattus norvegicus | i.e. arachidonoyl ethanolamide | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | Rattus norvegicus Sprague-Dawley | i.e. arachidonoyl ethanolamide | arachidonic acid + ethanolamine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Rattus norvegicus | - |
female | - |
Rattus norvegicus Sprague-Dawley | - |
female | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
urinary bladder | full-wall bladder and mucosa, urothelium, no FAAH immunoreactivity in other structures of the bladder | Mus musculus | - |
urinary bladder | mucosa, urothelium, no FAAH immunoreactivity in other structures of the bladder | Homo sapiens | - |
urinary bladder | mucosa, urothelium, no FAAH immunoreactivity in other structures of the bladder | Rattus norvegicus | - |
urothelium | - |
Homo sapiens | - |
urothelium | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
anandamide + H2O | i.e. arachidonoyl ethanolamide | Mus musculus | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | i.e. arachidonoyl ethanolamide | Homo sapiens | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | i.e. arachidonoyl ethanolamide | Rattus norvegicus | arachidonic acid + ethanolamine | - |
? | |
anandamide + H2O | i.e. arachidonoyl ethanolamide | Rattus norvegicus Sprague-Dawley | arachidonic acid + ethanolamine | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 63000, about, SDS-PAGE | Mus musculus |
? | x * 63000, about, SDS-PAGE | Homo sapiens |
? | x * 63000, about, SDS-PAGE | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
FAAH | - |
Mus musculus |
FAAH | - |
Homo sapiens |
FAAH | - |
Rattus norvegicus |
General Information | Comment | Organism |
---|---|---|
malfunction | effects of FAAH inhibition on bladder function during urodynamics in awake rats, overview | Rattus norvegicus |
physiological function | endocannabinoid-degrading enzyme fatty acid amide hydrolase. FAAH substrates in the urinary bladder act via local CB2-mediated signals | Mus musculus |
physiological function | endocannabinoid-degrading enzyme fatty acid amide hydrolase. FAAH substrates in the urinary bladder act via local CB2-mediated signals | Homo sapiens |
physiological function | endocannabinoid-degrading enzyme fatty acid amide hydrolase. FAAH substrates in the urinary bladder act via local CB2-mediated signals | Rattus norvegicus |